@article{39381b46b91543089b28aff5bb3e1727,
title = "Addressing immune-related adverse events of cancer immunotherapy: How prepared are rheumatologists?",
keywords = "PD-1, T Cells, arthritis, autoimmunity, inflammation, multidisciplinary team-care",
author = "Marie Kostine and Cappelli, {Laura C.} and Cassandra Calabrese and Calabrese, {Leonard H.} and Bingham, {Clifton O.} and Christophe Richez and Gottenberg, {Jacques Eric} and Olivier Lambotte",
note = "Funding Information: Competing interests MK received speaking fees from BMS. LCC received research grant from BMS and reported consulting for Regeneron. COB has served as consultant for BMS, Regeneron and Genentech/Roche, and received grant support from BMS. CR received speaking fees from BMS, AstraZeneca and Genentech/Roche. J-EG received honoraries from BMS and Pfizer and research grant from BMS. OL received paid expert testimony and consultancy fees from BMS France, MSD and AstraZeneca, consultancy fees from Genzyme, and expert testimony for Janssen. CC and LHC declared no conflict of interest for this work.",
year = "2019",
month = jun,
day = "1",
doi = "10.1136/annrheumdis-2018-214748",
language = "English (US)",
volume = "78",
pages = "860--862",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "6",
}